Very Rare Cancer Consortium Tumor Board Meeting

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

Thursday, July 16, 2020
4pm – 6pm 

HEMATOLOGIC MALIGNANCIES IN CHILDREN
AND YOUNG ADULTS

Case Conference 

This will be a VIRTUAL meeting via Zoom.
Please note registration is required.

SPEAKERS

Jing Chen, MD  Pediatric Hematology-Oncology Hackensack Meridian Health Hackensack University Medical Center “12 months old MLL-rearranged ALL relapse with lineage switch to AML with extensive extramedullary disease”

Gabriel Robbins, MD Assistant Professor of Pediatrics Hassenfeld Children’s Hospital at NYU Langone Health Division of Pediatric Hematology/Oncology “Adolescent with Ph-like B-ALL and hyperdiploidy, with overexpression of both CRLF2 and EPOR”

Jaclyn Rosenzweig, MD Pediatric Hematology-Oncology Fellow Memorial Sloan Kettering Cancer Center NewYork Presbyterian/Weill Cornell Medical Center “10 month old with FUS-ERG fusion infant B-ALL”

Neal Shukla, MD Pediatric Oncologist Memorial Sloan Kettering Cancer Center “21 year old with extramedullary relapse of mixed phenotype acute leukemia”

Lauren Weintraub, MD  Director of Brain Tumor Program Albany Medical College “22 year old female isolated extramedullary AML relapse post-HSCT”

Maria Luisa Sulis, MD, MS Chief, Pediatric Hematologic Malignancies Service Memorial Sloan Kettering Cancer Center “Three teenagers with CML and an unusual BCR-ABL mutation of unknown significance”